Search
forResearch 10 of 1000+
- Rethinking Oral Minoxidil: Distinguishing the Hair-Growth Window from the Cardiovascular Threshold
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts
- CUTANEOUS MANIFESTATIONS OF HIV-INFECTION IN RELATION WITH CD4 CELL COUNTS IN HADOTI REGION
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Transgender and Migraine
- Oral minoxidil bio‐activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss
- Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
Community 10 of 1000+
- Second Shed on Oral Min+Fin: Retrograde Thinning Concern
- 3 month Dut .1mg 1.1fin 5mg oral minoxidil plus topical.
- 2 years on 0.5mg dutasteride, 5mg oral minoxidil
- Experience with oral minoxidil/cautionary tale
- M33 (oral ) fin, min and dermastamp
- Dutasteride 2.5mg and oral min 5mg
- Derm wants to start with oral min only?
- Would it be dumb for me to switch to oral minoxidil?
- Topical min 13 months and oral fin 6 months, progress
- Transition from topical to oral minoxidil?
Learn
— no results
Try a deeper search in learn →